000 | 01996 a2200577 4500 | ||
---|---|---|---|
005 | 20250516034703.0 | ||
264 | 0 | _c20111209 | |
008 | 201112s 0 0 eng d | ||
022 | _a1521-009X | ||
024 | 7 |
_a10.1124/dmd.110.037234 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBungay, Peter J | |
245 | 0 | 0 |
_aPreclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist. _h[electronic resource] |
260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cAug 2011 |
||
300 |
_a1396-405 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aCaco-2 Cells |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aHepatocytes _xenzymology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIntestinal Secretions _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aPyrazoles _xblood |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Progesterone _xantagonists & inhibitors |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 |
_aSulfones _xblood |
650 | 0 | 4 | _aTandem Mass Spectrometry |
700 | 1 | _aTweedy, Sarah | |
700 | 1 | _aHowe, David C | |
700 | 1 | _aGibson, Karl R | |
700 | 1 | _aJones, Hannah M | |
700 | 1 | _aMount, Natalie M | |
773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 39 _gno. 8 _gp. 1396-405 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/dmd.110.037234 _zAvailable from publisher's website |
999 |
_c20807358 _d20807358 |